About Us
Our vision
A world with no blood group antibodies !
Blood barriers have protected individuals from potentially pathogenic exogenous organisms for thousands of years, but today they greatly complicate our modern health system where products are shared between individuals.
The future of health involves the elimination of blood groups.
– Plasma can be transfused regardless of donor and recipient respective blood group thanks to generalized universal plasma
– The issue of short-lived platelets is highly simplified because there is only one type of platelets: universal platelets
– Organ transplants can be done irrespective of donors & recipients blood group
– IVIG market is become much safer because those plasma derivative products do not contain isoagglutinins any more
Our Team
Henri SORS
“The Seasoned Entrepreneur”
He is the co-founder and CEO. Background of EE engineering +MBA. 25 years with Hewlett-Packard.
Bernard MANDRAND
“The Idea Wrangler”.
He is co-founder and scientific manager; 33 years at bioMerieux and 7 year at Lyonbiopole head of research programs.
Vivien DELOULE
“The multitasking specialist”.
He is the operations manager. Engineering degree and Ph. Balances lab logistics, supply chain nightmares, and frantic grant deadlines without breaking a sweat.
Ludovic BASTIDE
“The Bacteria Whisperer”
He is the technical manager. PhD in microbiology. Transforms biology madness into structured workflows while keeping everyone (mostly) sane.
Jacqueline HUET
“The Compliance Gatekeeper”
She is our quality manager.
David CUCCOLO
“ The Human Calculator “.
He is our financial manager. Speaks fluent Excel, sees the future in cash flow, and ensures the company doesn’t go broke.
Our History
We created GlycoBAR in 2015, in the heart of one of the biggest glycoscience clusters in the world, Grenoble in France.
Nourished by the ecosystem of innovation where world-class research laboratories rub shoulders with cutting-edge industries in medical technologies, nanotechnologies, semiconductors and life sciences.
GlycoBAR is growing to become a leader in glycoscience serving human health.